Apollon Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.95M | Buy |
|
|||||
|
2025
Q2 | $1.76M | Sell |
|
|||||
|
2025
Q1 | $2.22M | Buy |
|
|||||
|
2024
Q4 | $1.23M | Buy |
|
|||||
|
2024
Q3 | $1.67M | Sell |
|
|||||
|
2024
Q2 | $1.76M | Sell |
|
|||||
|
2024
Q1 | $1.64M | Buy |
|
|||||
|
2023
Q4 | $1.13M | Buy |
|
|||||
|
2023
Q3 | $801K | Buy |
|
|||||
|
2023
Q2 | $655K | Buy |
|
|||||
|
2023
Q1 | $624K | Sell |
|
|||||
|
2022
Q4 | $577K | Sell |
|
|||||
|
2022
Q3 | $938K | Buy |
|
|||||
|
2022
Q2 | $740K | Sell |
|
|||||
|
2022
Q1 | $922K | Sell |
|
|||||
|
2021
Q4 | $853K | Buy |
|
|||||
|
2021
Q3 | $738K | Sell |
|
|||||
|
2021
Q2 | $822K | Sell |
|
|||||
|
2021
Q1 | $846K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $10K | Buy |
|